Is the Apolipoprotein E Genotype a Biomarker for Mild Cognitive Impairment? Findings From a Nationally Representative Study

Neuropsychology

Volumn 25, Issue 6, 2011, Pages 679-689

  Brainerd, Charles J ^a   Reyna, Valerie F ^a   Petersen, Ronald C ^b   Smith, Glenn E ^b   Taub, Emily S ^a  

^a Department of Obstetrics Gynecology   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alzheimer's dementia; APOE genotype; Mild cognitive impairment

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEMENTIA; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC TESTING; GENOTYPE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE ON AGING (U.S.); NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UNITED STATES;

EID: 82855171505     PISSN: 08944105     EISSN: 19311559     Source Type: Journal    
DOI: 10.1037/a0024483     Document Type: Article

References (66)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
2. Anderson J.W., Schmitter-Edgecombe M. Mild cognitive impairment and feeling-of-knowing in episodic memory. Journal of Clinical and Experimental Neuropsychology 2010, 32:505-514.
3. Anstey K., Christensen H. Education, activity, health, blood pressure, and apolipoprotein E as predictors of cognitive change in old age: A review. Gerontology 2000, 46:163-177.
4. Bartrés-Faz D., Clemente I.C., Valveny J.N., López-Alomar A., Sánchez-Aldeguer J., López-Guillén A., Moral P. APOE and APOC1 genetic polymorphisms in age-associated memory impairment. Neurogenetics 2001, 3:215-219.
5. Benton A.L., Hamsher K., Varney N., Spreen O. Contributions to neuropsychological assessment 1983, Oxford University Press, New York.
6. Bhalla R.K., Butters M.A., Becker J.T., Houck P.R., Snitz B.E., Lopez O.L., Reynolds C.F. Patterns of mild cognitive impairment after treatment of depression in the elderly. American Journal of Geriatric Psychiatry 2009, 17:308-316.
7. Bizzozero I., Lucchelli F., Saetti M.C., Spinnler H. Mild cognitive impairment does entail retrograde amnesia for public events. Journal of Clinical and Experimental Neuropsychology 2009, 31:48-56.
8. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance A.M., Mazziota J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine 2000, 343:450-456.
9. Brainerd C.J., Reyna V.F., Howe M.L. Trichotomous processes in early memory development, aging, and neurocognitive impairment: A unified theory. Psychological Review 2009, 116:783-832.
10. Brandt J., Spencer M., Folstein M. The telephone interview for cognitive status. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1988, 1:111-117.
11. Bretsky P., Guralnik J.M., Launer L., Albert M., Seeman T.E. The role of APOE-e{open}4 in longitudinal cognitive decline: MacArthur studies of successful aging. Neurology 2003, 60:1077-1081.
12. Burggren A.C., Zeineh M.M., Ekstrom A.D., Braskie M.N., Thompson P.M., Small G.W., Bookheimer S.Y. Neuroimage 2008, 41:1177-1183.
13. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., Reiman E.M. Longitudinal modeling of age-related memory decline and the APOE e{open}4 effect. New England Journal of Medicine 2009, 361:255-263.
14. Collie A., Maruff P., Currie J. Behavioral characterization of mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology 2002, 24:720-733.
15. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.A., Pericakvance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
16. Crook T., Bartus R.T., Ferris S.H., Whitehouse P., Cohen G.D., Gershon S. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change - Report of a National Institute of Mental Health Work Group. Developmental Neuropsychology 1986, 2:261-276.
17. Devanand D.P., Pelton G.H., Zamora D., Liu X., Tabert M.H., Goodkind M., Mayeux R. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Archives of Neurology 2005, 62:975-980.
18. Duchek J.M., Balota D.A., Tse C-S., Holtzman D.M., Goate A.M. The utility of intraindividual variability in selective attention tasks as an early marker for Alzheimer's disease. Neuropsychology 2009, 23:746-758.
19. Fisk J.D., Merry H.R., Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003, 61:1179-1184.
20. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: A practical method of grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
21. Fuld P. Fuld Object-Memory Evaluation - Instruction Manual 1977, Stoelting, Wood Dale, IL.
22. Graham J.E., Rockwood K., Beattie B.L., Eastwood R., Gauthier S., Tuokko H., McDowell I. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997, 349:1793-1796.
23. Hayden K.M., Zandi P.P., West N.A., Tschanz J.T., Norton M.C., Corcoran C., Welsh-Bohmer K.A. Effects of family history and Apolipoprotein E epsilon 4 status on cognitive decline in the absence of Alzheimer dementia: The Cache County study. Archives of Neurology 2009, 66:1378-1383.
24. Health and Retirement Study [ADAMS] (2011). Public use dataset. Produced and distributed by the University of Michigan with funding from the National Institute on Aging (grant number NIA U01AG009740, Ann Arbor, MI).
25. Henderson A.S., Easteal S., Jorm A.F., Mackinnon A.J., Korten A.E., Christensen H., Jacomb P.A. Apolipoprotein E allele e{open}4, dementia, and cognitive decline in a population sample. The Lancet 1995, 346:1387-1390.
26. Heun R., Gühne U., Luck T., Angermeyer M.C., Ueberham U., Potluri R., Riedel-Heller S.G. Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment. European Psychiatry 2010, 25:15-18.
27. Jarvik G.P., Wijsman E.M., Kukull W.A., Schellenberg G.D., Yu C., Larson E.B. Interactions of apolipoprotein E genotype, total cholesterol level, age and sex in prediction of Alzheimer's disease: A case control study. Neurology 1995, 45:1092-1096.
28. Johnson S.C., Schmitz T.W., Asthana S., Gluck M.A., Myers C. Associative learning over trials activates the hippocampus in healthy elderly but not mild cognitive impairment. Aging, Neuropsychology, and Cognition 2008, 15:129-145.
29. Juster F.T., Suzman R. An overview of the Health and Retirement Study. Journal of Human Resources 1995, 30:S7-S56.
30. Langa K., Plassman B., Wallace R., Herzog A.R., Heeringa S., Ofstedal M.B., Willis R. The Aging, Demographics and Memory Study: Study design and methods. Neuroepidemiology 2005, 25:181-191.
31. Levy R. Aging-associated cognitive decline. International Psychogeriatrics 1994, 6:63-68.
32. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Diagnosis of Alzheimer's diseases: Report of the NINCDS-ADRA Work Group under the auspices of Department of Health and Human Services Task-Force on Alzheimer's disease. Neurology 1984, 34:939-944.
33. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., VanBelle G., Fillenbaum G., Clark C. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
34. Panza F., D'Introno A., Colacicco A.M., Capurso C., Del Parigi A., Caselli R.J., Solfrizzi V. Current epidemiology of mild cognitive impairment and other predementia syndromes. American Journal of Geriatric Psychiatry 2005, 13:633-644.
35. Parasuraman R., Greenwood P.M., Sunderland T. The Apolipoprotein E gene, attention, and brain function. Neuropsychology 2002, 16:254-274.
36. Petersen R.C. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004, 256:183-194.
37. Petersen R.C., Roberts R.O., Knopman D.S., Geda Y.E., Cha R.H., Pankratz V.S., Rocca W.A. Prevalence of mild cognitive impairment is higher in men: The Mayo Clinic study of aging. Neurology 2010, 75:889-897.
38. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., Kurland L.T. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Journal of the American Medical Association 1995, 273:1274-1278.
39. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology 1999, 56:303-308.
40. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1133-1142.
41. Plassman B.L., Langa K.M., Fisher G.G., Heeringa S.G., Weir D.R., Ofstedal M.B., Wallace R.B. Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology 2007, 29:125-132.
42. Plassman B.L., Langa K.M., Fisher G.G., Heeringa S.G., Weir D.R., Ofstedal M.B., Wallace R.B. Prevalence of cognitive impairment without dementia in the United States. Annals of Internal Medicine 2008, 148:427-434.
43. Reitan R.M. Trail Making Test: Manual for Administration and Scoring 1992, Reitan Neuropsychological Laboratory, Tuscon, AZ.
44. Scarmeas N., Habeck C.G., Stern Y., Anderson K.E. ApoE genotype and cerebral blood flow in healthy young individuals. Journal of the American Medical Association 2003, 290:1581-1582.
45. Schmitter-Edgecombe M., Sanders C. Task switching in mild cognitive impairment: Switch and nonswitch costs. Journal of the International Neuropsychological Society 2009, 15:103-111.
46. Schmitter-Edgecombe M., Woo E., Greeley D.R. Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment. Neuropsychology 2009, 23:168-177.
47. Seeman T.E., Huang M-H., Bretsky P., Crimmens E., Launer L., Guralnik J.M. Education and APOE-e4 in longitudinal cognitive decline: MacArthur studies of successful aging. The Journals of Gerontology 2005, 60B:74-83.
48. Seidenberg M., Guidotti L., Nielson K.A., Woodard J.L., Durgerian S., Zhang Q., Rao S.M. Semantic knowledge for famous names in mild cognitive impairment. Journal of the International Neuropsychological Society 2009, 15:9-18.
49. Serra L., Bozzali M., Cercignani M., Perri R., Fadda L., Caltagirone C., Carlesimo G.A. Recollection and familiarity in amnesic mild cognitive impairment. Neuropsychology 2010, 24:316-326.
50. Small B.J., Rosnick C.B., Fratiglioni L., Backman L. Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging 2004, 19:592-600.
51. Small G.W., Ercoli L.M., Silverman D.H.S., Huang S-C., Komo S., Bookheimer S.Y., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proceedings of the National Academy of Science 2000, 97:6037-6042.
52. Smith A. Symbol Digit Modalities Test-Manual 1982, Los Angeles, Western Psychological Services.
53. Smith G.E. Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease?. Journal of Neural Transmission: Suppl 2002, 62:S97-S104.
54. Snodgrass J.G., Corwin J. Pragmatics of measuring recognition memory: Applications to dementia and amnesia. Journal of Experimental Psychology: General 1988, 117:34-50.
55. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: High avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proceedings of the National Academy of Science 1993, 90:1977-1981.
56. Traykov L., Rigaud A.S., Baudic S., Smagghe A., Boller F., Forette F. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. Journal of Neurological Science 2002, 203-204:177-181.
57. Tschanz J.T., Welsh-Bohmer K.A., Lyketsos C.G., Corcoran C., Green R.C., Hayden K., Breitner J.C.S. Conversion to dementia from mild cognitive disorder: The Cache County study. Neurology 2006, 67:229-234.
58. Wechsler D. Wechsler Adult Intelligence Scales-Third Edition 1997, The Psychological Corporation, San Antonio, TX.
59. Welsh-Bohmer K.A., Ostbye T., Sanders L., Pieper C.F., Hayden K.M., Tschanz J.T., Norton M.C. Neuropsychological performance in advanced age: Influences of demographic factors and Apolipoprotein E: Findings from the Cache County memory study. Neuropsychologist 2009, 23:77-99.
60. Whitehair D.C., Sherzai A., Emond J., Raman R., Aisen P.S., Petersen R.C., Fleisher A.S. Influence of apolipoprotein E epsilon 4 on rates of cognitive and functional decline in mild cognitive impairment. Alzheimers & Dementia 2010, 6:412-419.
61. Wilkinson G.S. Wide Range Achievement Test 1993, Wide Range, Inc, Wilmington, DE.
62. Woodard J.L., Seidenberg M., Nielson K.A., Antuono P., Guidotti L., Durgerian S., Rao S.M. Semantic memory activation in amnestic mild cognitive impairment. Brain 2009, 132:2068-2078.
63. Xu G.F., Mclaren D.G., Ries M.L., Fitzgerald M.E., Bendlin B.B., Rowley H.A., Johnson S.C. Influence of parental history of Alzheimers disease and apolipoprotein E 4 on the BOLD signal during recognition memory. Brain 2009, 132:383-391.
64. Yonelinas A.P. The nature of recollection and familiarity: A review of 30 years of research. Journal of Memory and Language 2002, 46:441-518.
65. Zachary R.A. Shipley Institute of Living Scale 1986, Los Angeles: Western Psychological Services, Revised Manual.
66. Zill P., Engel R., Hampel H., Behrens S., Bürger K., Padberg F., Bondy B. Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients. European Archives of Psychiatry and Clinical Neuroscience 2001, 252:24-28.